Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2013 by Rapid City Regional Hospital, Inc
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Rapid City Regional Hospital, Inc
ClinicalTrials.gov Identifier:
NCT01706510
First received: October 10, 2012
Last updated: April 10, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)